{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:59:46Z","timestamp":1790855986749,"version":"4.1.0"},"reference-count":94,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>The respiratory system stands as one of the eight pivotal systems within the human body, responsible for a range of essential functions. Primarily, it facilitates the absorption of oxygen from the external environment and the expulsion of carbon dioxide, thereby playing a crucial role in regulating the body\u2019s acid-base balance. Furthermore, it helps to maintain the stability of the internal environment, ensuring the smooth progression of normal metabolic processes and sustaining life activities. In the wake of the novel coronavirus pneumonia outbreak, respiratory diseases have continued to exhibit comparatively high morbidity and mortality rates, underscoring the urgent need for the discovery of novel therapeutic agents. Tanshinone IIA (Tan IIA), a bioactive chemical constituent derived from <jats:italic>Salvia miltiorrhiza Bunge,<\/jats:italic> has emerged as a promising candidate. As a significant fat-soluble compound, Tan IIA has traditionally been utilized in the treatment of cardiovascular diseases. As research on Tan IIA has progressed, its multifaceted therapeutic potential has been unveiled. Specifically, Tan IIA has demonstrated anti-inflammatory, anti-oxidative stress, anti-fibrosis, and anti-cancer effects. In recent years, a wealth of studies has concentrated on elucidating its impact on various respiratory diseases, including asthma, chronic obstructive pulmonary disease, pulmonary hypertension, pulmonary fibrosis, acute lung injury\/acute respiratory distress syndrome, and lung cancer. These findings collectively suggest that Tan IIA holds considerable promise in the realm of anti-respiratory disease therapies. The present article undertakes a comprehensive review of the targets and potential mechanisms of Tan IIA against respiratory diseases, offering valuable insights that can serve as a reference for future research endeavors and clinical applications of Tan IIA in the treatment of respiratory ailments.<\/jats:p>","DOI":"10.3389\/fphar.2025.1505672","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T06:45:05Z","timestamp":1740379505000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Progress of tanshinone IIA against respiratory diseases: therapeutic targets and potential mechanisms"],"prefix":"10.3389","volume":"16","author":[{"given":"Zhaohui","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youlin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huie","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiwang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanrong","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengtao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.pulmoe.2019.04.002","article-title":"Strategies to relieve dyspnoea in patients with advanced chronic respiratory diseases. A narrative review","volume":"25","author":"Ambrosino","year":"2019","journal-title":"Pulmonology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"105364","DOI":"10.1016\/j.phrs.2020.105364","article-title":"Prospective therapeutic potential of Tanshinone IIA: an updated overview","volume":"164","author":"Ansari","year":"2021","journal-title":"Pharmacol. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3389\/fphar.2020.00687","article-title":"Sodium tanshinone II sulfonate A ameliorates hypoxia-induced pulmonary hypertension","volume":"11","author":"Bao","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jama.2016.0291","article-title":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries","volume":"315","author":"Bellani","year":"2016","journal-title":"JAMA-J. Am. Med. Assoc."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/S0140-6736(22)01485-4","article-title":"Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes","volume":"400","author":"Bos","year":"2022","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA-Cancer J. Clin."},{"key":"B7","doi-asserted-by":"publisher","first-page":"116207","DOI":"10.1016\/j.bcp.2024.116207","article-title":"Tanshinone IIA acts as a regulator of lipogenesis to overcome osimertinib acquired resistance in lung cancer","volume":"224","author":"Cao","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e0178226","DOI":"10.1371\/journal.pone.0178226","article-title":"Sodium tanshinone IIA sulfonate stimulated Cl-secretion in mouse trachea","volume":"12","author":"Chen","year":"2017","journal-title":"PLoS One"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.3390\/molecules28041990","article-title":"Renoprotective effects of tanshinone IIA: a literature review","volume":"28","author":"Chen","year":"2023","journal-title":"Molecules"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1016\/S0140-6736(22)00470-6","article-title":"Chronic obstructive pulmonary disease","volume":"399","author":"Christenson","year":"2022","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1001\/jama.2017.21907","article-title":"Acute respiratory distress syndrome: advances in diagnosis and treatment","volume":"319","author":"Fan","year":"2018","journal-title":"JAMA-J. Am. Med. Assoc."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1001\/jama.294.22.2889","article-title":"Ventilatory management of acute lung injury and acute respiratory distress syndrome","volume":"294","author":"Fan","year":"2005","journal-title":"JAMA-J. Am. Med. Assoc."},{"key":"B13","doi-asserted-by":"publisher","first-page":"611087","DOI":"10.3389\/fphar.2020.611087","article-title":"Tanshinone IIA: a review of its anticancer effects","volume":"11","author":"Fang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"109024","DOI":"10.1016\/j.cbi.2020.109024","article-title":"Tanshinone IIA attenuates silica-induced pulmonary fibrosis via Nrf2-mediated inhibition of EMT and TGF-\u03b21\/Smad signaling","volume":"319","author":"Feng","year":"2020","journal-title":"Chem.-Biol. Interact."},{"key":"B15","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.2147\/DDDT.S230572","article-title":"The protective role of tanshinone IIA in silicosis rat model via TGF-\u03b21\/smad signaling suppression, NOX4 inhibition and Nrf2\/ARE signaling activation","volume":"13","author":"Feng","year":"2019","journal-title":"Drug Des. Devel Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.3390\/ijms25052903","article-title":"Animals in respiratory research","volume":"25","author":"Frohlich","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.2147\/OTT.S246606","article-title":"Inhibition of EGFR signaling and activation of mitochondrial apoptosis contribute to tanshinone IIA-mediated tumor suppression in non-small cell lung cancer cells","volume":"13","author":"Gao","year":"2020","journal-title":"OncoTargets Ther."},{"key":"B18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3389\/fphar.2018.00263","article-title":"Sodium tanshinone IIA sulfonate decreases cigarette smoke-induced inflammation and oxidative stress via blocking the activation of MAPK\/HIF-1\u03b1 signaling pathway","volume":"9","author":"Guan","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/toxsci\/kfab087","article-title":"Sodium tanshinone IIA sulfonate attenuates cigarette smoke extract-induced mitochondrial dysfunction, oxidative stress, and apoptosis in alveolar epithelial cells by enhancing SIRT1 pathway","volume":"183","author":"Guan","year":"2021","journal-title":"Toxicol. Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.3892\/mmr.2015.3333","article-title":"Tanshinone IIA attenuates bleomycin-induced pulmonary fibrosis in rats","volume":"11","author":"He","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.intimp.2018.12.010","article-title":"Anti-allergic effects of salvianolic acid A and tanshinone IIA from Salvia miltiorrhiza determined using in vivo and in vitro experiments","volume":"67","author":"Heo","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"106209","DOI":"10.1016\/j.phrs.2022.106209","article-title":"Acetyltanshinone IIA reduces the synthesis of cell cycle-related proteins by degrading p70S6K and subsequently inhibits drug-resistant lung cancer cell growth","volume":"179","author":"Huang","year":"","journal-title":"Pharmacol. Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.2174\/0929867328666211108110025","article-title":"Tanshinone IIA: pharmacology, total synthesis, and progress in structure-modifications","volume":"29","author":"Huang","year":"","journal-title":"Curr. Med. Chem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.jep.2009.07.020","article-title":"Effects of sodium tanshinone II A sulphonate on hypoxic pulmonary hypertension in rats in vivo and on Kv2.1 expression in pulmonary artery smooth muscle cells in vitro","volume":"125","author":"Huang","year":"2009","journal-title":"J. Ethnopharmacol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"173352","DOI":"10.1016\/j.ejphar.2020.173352","article-title":"Salvianolic acid B and sodium tanshinone II A sulfonate prevent pulmonary fibrosis through anti-inflammatory and anti-fibrotic process","volume":"883","author":"Jiang","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"C136","DOI":"10.1152\/ajpcell.00252.2015","article-title":"Sodium tanshinone IIA sulfonate inhibits hypoxia-induced enhancement of SOCE in pulmonary arterial smooth muscle cells via the PKG-PPAR-gamma signaling axis","volume":"311","author":"Jiang","year":"2016","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12906-024-04363-y","article-title":"Tanshinone IIA inhibits proliferation and migration by downregulation of the PI3K\/Akt pathway in small cell lung cancer cells","volume":"24","author":"Jiang","year":"2024","journal-title":"BMC Complement. Med. Ther."},{"key":"B28","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3389\/fphar.2019.00202","article-title":"Tanshinones, critical pharmacological components in Salvia miltiorrhiza","volume":"10","author":"Jiang","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.3892\/ijo.2016.3441","article-title":"Tanshinone IIA induces TRAIL sensitization of human lung cancer cells through selective ER stress induction","volume":"48","author":"Kim","year":"2016","journal-title":"Int. J. Oncol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","article-title":"The global burden of lung cancer: current status and future trends","volume":"20","author":"Leiter","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"106261","DOI":"10.1016\/j.intimp.2020.106261","article-title":"Sodium tanshinone IIA sulfonate protects against acute exacerbation of cigarette smoke-induced chronic obstructive pulmonary disease in mice","volume":"81","author":"Li","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/s41598-017-18745-5","article-title":"Tanshinone IIA sulfonate protects against cigarette smoke-induced COPD and down-regulation of CFTR in mice","volume":"8","author":"Li","year":"2018","journal-title":"Sci. Rep."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s10557-024-07607-8","article-title":"Tanshinone IIA through the PGK1\/PDHK1 pathway affecting macrophage reprogramming in the repair process of myocardial infarction","volume":"38","author":"Li","year":"2024","journal-title":"Cardiovasc. Drugs Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.apjtm.2016.09.003","article-title":"Anti-tumor activity of tanshinone IIA in combined with cyclophosphamide against Lewis mice with lung cancer","volume":"9","author":"Li","year":"2016","journal-title":"Asian pac. J. Trop. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"23681","DOI":"10.1038\/s41598-021-03166-2","article-title":"Tanshinone IIA suppresses the progression of lung adenocarcinoma through regulating CCNA2-CDK2 complex and AURKA\/PLK1 pathway","volume":"11","author":"Li","year":"2021","journal-title":"Sci. Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1002\/ptr.6392","article-title":"Tanshinone IIA combined with cisplatin synergistically inhibits non-small-cell lung cancer in vitro and in vivo via down-regulating the phosphatidylinositol 3-kinase\/Akt signalling pathway","volume":"33","author":"Liao","year":"2019","journal-title":"Phytother. Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"116021","DOI":"10.1016\/j.taap.2022.116021","article-title":"Tanshinone IIA improves sepsis-induced acute lung injury through the ROCK2\/NF-\u03baB axis","volume":"446","author":"Liu","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.freeradbiomed.2020.02.032","article-title":"Tanshinone IIA alleviates blast-induced inflammation, oxidative stress and apoptosis in mice partly by inhibiting the PI3K\/Akt\/FoxO1 signaling pathway","volume":"152","author":"Liu","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1042\/CS20210879","article-title":"Pathogenesis of pneumonia and acute lung injury","volume":"136","author":"Long","year":"2022","journal-title":"Clin. Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e56774","DOI":"10.1371\/journal.pone.0056774","article-title":"Tanshinone IIA inhibits hypoxia-induced pulmonary artery smooth muscle cell proliferation via Akt\/Skp2\/p27-associated pathway","volume":"8","author":"Luo","year":"2013","journal-title":"PLoS One"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1016\/j.apsb.2021.09.008","article-title":"Traditional Chinese medicine in COVID-19","volume":"11","author":"Lyu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"B42","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S1875-5364(19)30010-X","article-title":"Danshen: a phytochemical and pharmacological overview","volume":"17","author":"Meim","year":"2019","journal-title":"Chin. J. Nat. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.rmed.2010.02.010","article-title":"Pharmacological and non-pharmacological interventions for cough in adults with respiratory and non-respiratory diseases: a systematic review of the literature","volume":"104","author":"Molassiotis","year":"2010","journal-title":"Respir. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jtho.2021.11.003","article-title":"The 2021 WHO classification of lung tumors: impact of advances since 2015","volume":"17","author":"Nicholson","year":"2022","journal-title":"J. Thorac. Oncol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/S0140-6736(22)02125-0","article-title":"Asthma","volume":"401","author":"Porsbjerg","year":"2023","journal-title":"Lancet."},{"key":"B46","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3892\/ol.2022.13304","article-title":"Tanshinone IIA inhibits cell growth by suppressing SIX1-induced aerobic glycolysis in non-small cell lung cancer cells","volume":"23","author":"Qi","year":"2022","journal-title":"Oncol. Lett."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1111\/jphp.13087","article-title":"Tanshinone IIA protects against lipopolysaccharide-induced lung injury through targeting Sirt1","volume":"71","author":"Quan","year":"2019","journal-title":"J. Pharm. Pharmacol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1161\/CIRCRESAHA.113.301141","article-title":"Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension","volume":"115","author":"Rabinovitch","year":"2014","journal-title":"Circ. Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3389\/fphar.2019.00753","article-title":"Salvia miltiorrhiza in treating cardiovascular diseases: a review on its pharmacological and clinical applications","volume":"10","author":"Ren","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1158\/1055-9965.EPI-19-0221","article-title":"Cancer progress and priorities: lung cancer","volume":"28","author":"Schabath","year":"2019","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"B51","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/17425247.2019.1553955","article-title":"Future of nanomedicines for treating respiratory diseases","volume":"16","author":"Scherliess","year":"2019","journal-title":"Expert Opin. Drug Deliv."},{"key":"B52","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3238\/arztebl.m2023.0012","article-title":"Personalized treatment for patients with lung cancer","volume":"120","author":"Schuler","year":"2023","journal-title":"Dtsch. Arztebl. Int."},{"key":"B53","doi-asserted-by":"publisher","first-page":"105661","DOI":"10.1016\/j.phrs.2021.105661","article-title":"Tanshinone IIA: a phytochemical as a promising drug candidate for neurodegenerative diseases","volume":"169","author":"Subedi","year":"2021","journal-title":"Pharmacol. Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1007\/s11010-022-04646-3","article-title":"Tanshinone IIA (TSIIA) represses the progression of non-small cell lung cancer by the circ_0020123\/miR-1299\/HMGB3 pathway","volume":"478","author":"Sun","year":"2023","journal-title":"Mol. Cell. Biochem."},{"key":"B55","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/JLB.5MA1120-776RR","article-title":"Tanshinone IIA enhances susceptibility of non-small cell lung cancer cells to NK cell-mediated lysis by up-regulating ULBP1 and DR5","volume":"110","author":"Sun","year":"2021","journal-title":"J. Leukoc. Biol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"617393","DOI":"10.3389\/fmed.2021.617393","article-title":"Tanshinone IIA combined with cyclosporine A alleviates lung apoptosis induced by renal ischemia-reperfusion in obese rats","volume":"8","author":"Tai","year":"2021","journal-title":"Front. Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s11655-017-2424-x","article-title":"Sodium tanshinone II A sulfonate injection as adjuvant treatment for unstable angina pectoris: a meta-analysis of 17 randomized controlled trials","volume":"24","author":"Tan","year":"2018","journal-title":"Chin. J. Integr. Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jss.2015.02.062","article-title":"Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-\u03b2-dependent epithelial to mesenchymal transition","volume":"197","author":"Tang","year":"2015","journal-title":"J. Surg. Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3390\/molecules29061201","article-title":"Research progress on regulation of immune response by tanshinones and salvianolic acids of danshen (Salvia miltiorrhiza Bunge)","volume":"29","author":"Tang","year":"2024","journal-title":"Molecules"},{"key":"B60","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.canlet.2010.04.020","article-title":"A novel compound modified from tanshinone inhibits tumor growth in vivo via activation of the intrinsic apoptotic pathway","volume":"297","author":"Tian","year":"2010","journal-title":"Cancer Lett."},{"key":"B61","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1517\/13543776.2013.736494","article-title":"Tanshinone derivatives: a patent review (January 2006 - september 2012)","volume":"23","author":"Tian","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"B62","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1080\/13880209.2023.2204879","article-title":"Sodium tanshinone IIA sulphate inhibits angiogenesis in lung adenocarcinoma via mediation of miR-874\/eEF-2K\/TG2 axis","volume":"61","author":"Wang","year":"2023","journal-title":"Pharm. Biol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"152793","DOI":"10.1016\/j.phymed.2018.12.016","article-title":"Development of sustained-release pellets to modulate the in vivo processes of the main active components of Danshen: a pharmacokinetic and pharmacodynamic evaluation","volume":"58","author":"Wang","year":"","journal-title":"Phytomedicine"},{"key":"B64","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ejphar.2010.04.047","article-title":"Tanshinone IIA modulates pulmonary vascular response to agonist and hypoxia primarily via inhibiting Ca2+ influx and release in normal and hypoxic pulmonary hypertension rats","volume":"640","author":"Wang","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1165\/rcmb.2012-0071OC","article-title":"Sodium tanshinone IIA sulfonate inhibits canonical transient receptor potential expression in pulmonary arterial smooth muscle from pulmonary hypertensive rats","volume":"48","author":"Wang","year":"","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"114986","DOI":"10.1016\/j.bcp.2022.114986","article-title":"Sodium tanshinone IIA sulfonate enhances the BMP9-BMPR2-Smad1\/5\/9 signaling pathway in rat pulmonary microvascular endothelial cells and human embryonic stem cell-derived endothelial cells","volume":"199","author":"Wang","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3978\/j.issn.2072-1439.2013.02.04","article-title":"Promising therapeutic effects of sodium tanshinone IIA sulfonate towards pulmonary arterial hypertension in patients","volume":"5","author":"Wang","year":"","journal-title":"J. Thorac. Dis."},{"key":"B68","doi-asserted-by":"publisher","first-page":"9355","DOI":"10.2147\/OTT.S221228","article-title":"Tanshinone IIA reverses gefitinib-resistance in human non-small-cell lung cancer via regulation of VEGFR\/Akt pathway","volume":"12","author":"Wang","year":"","journal-title":"OncoTargets Ther."},{"key":"B69","doi-asserted-by":"publisher","first-page":"160","DOI":"10.22038\/ijbms.2018.30598.7375","article-title":"Tanshinone IIA attenuates ovalbumin-induced airway inflammation and hyperresponsiveness in a murine model of asthma","volume":"22","author":"Wang","year":"","journal-title":"J. Basic Med. Sci."},{"key":"B70","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.3892\/mmr.2018.9281","article-title":"Tanshinone IIA attenuates paraquat-induced acute lung injury by modulating angiotensin-converting enzyme 2\/angiotensin-(1-7) in rats","volume":"18","author":"Wang","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"B71","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1056\/NEJMra2005230","article-title":"Spectrum of fibrotic lung diseases","volume":"383","author":"Wijsenbeek","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B72","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0140-6736(22)01052-2","article-title":"Interstitial lung diseases","volume":"400","author":"Wijsenbeek","year":"2022","journal-title":"Lancet"},{"key":"B73","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1146\/annurev-bioeng-110122-010848","article-title":"Recent developments in aerosol pulmonary drug delivery: new technologies, new cargos, and new targets","volume":"26","author":"Woodward","year":"2024","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"B74","doi-asserted-by":"publisher","first-page":"578","DOI":"10.7150\/ijms.8365","article-title":"Tanshinone IIA attenuates bleomycin-induced pulmonary fibrosis via modulating angiotensin-converting enzyme 2\/angiotensin-(1-7) axis in rats","volume":"11","author":"Wu","year":"2014","journal-title":"Int. J. Med. Sci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"e0290841","DOI":"10.1371\/journal.pone.0290841","article-title":"The efficacy and safety of sodium tanshinone \u2161A sulfonate injection in the treatment of unstable angina pectoris: a systematic review and meta-analysis","volume":"18","author":"Wu","year":"2023","journal-title":"PLoS One"},{"key":"B76","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.apsb.2015.07.008","article-title":"The antitumor effect of tanshinone IIA on anti-proliferation and decreasing VEGF\/VEGFR2 expression on the human non-small cell lung cancer A549 cell line","volume":"5","author":"Xie","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"B77","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1186\/s12885-016-2921-x","article-title":"Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way","volume":"16","author":"Xie","year":"2016","journal-title":"BMC Cancer"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1165\/rcmb.2011-0113OC","article-title":"Tanshinone IIA-induced attenuation of lung injury in endotoxemic mice is associated with reduction of hypoxia-inducible factor 1\u03b1 expression","volume":"45","author":"Xu","year":"2011","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ejphar.2009.02.003","article-title":"Tanshinone IIA reduces lethality and acute lung injury in LPS-treated mice by inhibition of PLA2 activity","volume":"607","author":"Xu","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ejps.2015.05.012","article-title":"Tanshinone IIA - loaded pellets developed for angina chronotherapy: deconvolution-based formulation design and optimization, pharmacokinetic and pharmacodynamic evaluation","volume":"76","author":"Yan","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"B81","doi-asserted-by":"publisher","first-page":"107139","DOI":"10.1016\/j.jbc.2024.107139","article-title":"Tanshinone analog inhibits castration-resistant prostate cancer cell growth by inhibiting glycolysis in an AR-dependent manner","volume":"300","author":"Yu","year":"2024","journal-title":"J. Biol. Chem."},{"key":"B82","doi-asserted-by":"publisher","first-page":"102285","DOI":"10.1016\/j.pupt.2024.102285","article-title":"Tanshinone IIA alleviates bleomycin-induced pulmonary fibrosis by inhibiting Zbtb16","volume":"84","author":"Zhang","year":"","journal-title":"Pulm. Pharmacol. Ther."},{"key":"B83","doi-asserted-by":"publisher","first-page":"153297","DOI":"10.1016\/j.phymed.2020.153297","article-title":"Therapeutic options of TCM for organ injuries associated with COVID-19 and the underlying mechanism","volume":"85","author":"Zhang","year":"2021","journal-title":"Phytomedicine"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/ptr.8130","article-title":"Tanshinone IIA reverses gefitinib resistance in EGFR-mutant lung cancer via inhibition of SREBP1-mediated lipogenesis","volume":"38","author":"Zhang","year":"","journal-title":"Phytother. Res."},{"key":"B85","doi-asserted-by":"publisher","first-page":"9603271231180864","DOI":"10.1177\/09603271231180864","article-title":"Tanshinone IIA inhibits ischemia-reperfusion-induced inflammation, ferroptosis and apoptosis through activation of the PI3K\/Akt\/mTOR pathway","volume":"42","author":"Zhang","year":"2023","journal-title":"Hum. Exp. Toxicol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1533033820928073","DOI":"10.1177\/1533033820928073","article-title":"Sodium tanshinone IIA sulfonate attenuates tumor oxidative stress and promotes apoptosis in an intermittent hypoxia mouse model","volume":"19","author":"Zhang","year":"2020","journal-title":"Technol. Cancer Res. Treat."},{"key":"B87","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.18632\/aging.205531","article-title":"Sodium tanshinone IIA sulfonate inhibits tumor growth via miR-138 upregulation in intermittent hypoxia-induced xenograft mice","volume":"16","author":"Zhang","year":"","journal-title":"Aging (Albany NY)"},{"key":"B88","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1055\/s-0042-119950","article-title":"Relaxant effect of sodium tanshinone IIA sulphonate on mouse tracheal smooth muscle","volume":"83","author":"Zhang","year":"2017","journal-title":"Planta Med."},{"key":"B89","doi-asserted-by":"publisher","first-page":"155431","DOI":"10.1016\/j.phymed.2024.155431","article-title":"Tanshinone IIA induces ER stress and JNK activation to inhibit tumor growth and enhance anti-PD-1 immunotherapy in non-small cell lung cancer","volume":"128","author":"Zhang","year":"","journal-title":"Phytomedicine"},{"key":"B90","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.joim.2022.01.006","article-title":"Tanshinone IIA prevents acute lung injury by regulating macrophage polarization","volume":"20","author":"Zhao","year":"2022","journal-title":"J. Integr. Med.-JIM."},{"key":"B91","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.resp.2014.09.025","article-title":"Tanshinone IIA attenuates hypoxic pulmonary hypertension via modulating KV currents","volume":"205","author":"Zheng","year":"2015","journal-title":"Respir. Physiol. Neuro."},{"key":"B92","doi-asserted-by":"publisher","first-page":"109362","DOI":"10.1016\/j.biopha.2019.109362","article-title":"Sodium tanshinone IIA sulfonate: a review of pharmacological activity and pharmacokinetics","volume":"118","author":"Zhou","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"B93","doi-asserted-by":"publisher","first-page":"22928","DOI":"10.1038\/s41598-023-50163-8","article-title":"Drug monomers from Salvia miltiorrhiza Bge. promoting tight junction protein expression for therapeutic effects on lung cancer","volume":"13","author":"Zhu","year":"2023","journal-title":"Sci. Rep."},{"key":"B94","doi-asserted-by":"publisher","first-page":"103461","DOI":"10.1016\/j.etap.2020.103461","article-title":"Sodium tanshinone IIA sulfonate attenuates silica-induced pulmonary fibrosis in rats via activation of the Nrf2 and thioredoxin system","volume":"80","author":"Zhu","year":"2020","journal-title":"Environ. Toxicol. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1505672\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T06:45:16Z","timestamp":1740379516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1505672\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":94,"alternative-id":["10.3389\/fphar.2025.1505672"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1505672","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,24]]},"article-number":"1505672"}}